Cited by 277Neurogenesis and neuroplasticity mechanismsMultiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease

Open access
Tripathi, Richa B., Rivers, Leanne E., Young, Kaylene M., Jamen, Francoise, Richardson, William D.·2010·The Journal of Neuroscience

Abstract

The adult mammalian brain and spinal cord contain glial precursors that express platelet-derived growth factor receptor α subunit (PDGFRA) and the NG2 proteoglycan. These "NG2 cells" descend from oligodendrocyte precursors in the perinatal CNS and continue to generate myelinating oligodendrocytes in the gray and white matter of the postnatal brain. It has been proposed that NG2 cells can also generate reactive astrocytes at sites of CNS injury or demyelination. To test this we examined the fates of PDGFRA/NG2 cells in the mouse spinal cord during experimental autoimmune encephalomyelitis (EAE)--a demyelinating condition that models some aspects of multiple sclerosis in humans. We administered tamoxifen to Pdgfra-CreER(T2):Rosa26R-YFP mice to induce yellow fluorescent protein (YFP) expression in PDGFRA/NG2 cells and their differentiated progeny. We subsequently induced EAE and observed a large (>4-fold) increase in the local density of YFP(+) cells, >90% of which were oligodendrocyte lineage cells. Many of these became CC1-positive, NG2-negative differentiated oligodendrocytes that expressed myelin markers CNP and Tmem10/Opalin. PDGFRA/NG2 cells generated very few GFAP(+)-reactive astrocytes (1-2% of all YFP(+) cells) or NeuN(+) neurons (<0.02%). Thus, PDGFRA/NG2 cells act predominantly as a reservoir of new oligodendrocytes in the demyelinated spinal cord.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3411-10.2010

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At P120+7, 19.9% ± 3.2% of all optic nerve OPs (defined by NG2 immunolabeling) were YFP labeled, less than in adult corpus callosum (approximately 45%) or spinal cord (approximately 39%).

    “A short time later (P120+7), 19.9% ± 3.2% of all optic nerve OPs (defined by NG2 immunolabeling) were YFP labeled (mean ±SD, n = 3 mice), less than in the adult corpus callosum (∼45%; Rivers et al., 2008) or spinal cord (∼39%; Zawadzka et al., 2010; Tripathi et al., 2010).”

    From Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling (2013) · cites this paper as Tripathi et al., 2010

    The Materials and Methods section (Induction of EAE; page unavailable) reports that about 30% of spinal-cord PDGFRA+ cells became YFP+, compared with about 45–50% in the adult forebrain. This supports the regional comparison but not the cited ∼39% spinal-cord figure, and the paper measures PDGFRA+ rather than NG2-immunolabeled cells for that comparison. The 19.9% optic-nerve result is presented as the citing authors’ own finding, not as a result attributed to Tripathi et al. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The Cre/lox system has been used in reporter mice to track oligodendrogenesis and myelin synthesis during development, after CNS demyelination, and after SCI.

    “The Cre/lox system been used in reporter mice to track oligodendrogenesis and myelin synthesis during development [45, 81], after CNS demyelination [82, 83], and after SCI [44, 84, 85].”

    From Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury (2020) · cites this paper as [83]

    The Discussion reports using Cre-lox reporter mice to track new oligodendrocytes in an EAE demyelination model. But the Results state that the reporter did not label myelin sheaths and the authors could not determine whether the new oligodendrocytes formed myelin. The development and SCI portions of the sentence are attached to other citations. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tripathi, R. B., Rivers, L. E., Young, K. M., Jamen, F., & Richardson, W. D.
Affiliations
  • University College London (GB)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Richardson, William D.
Venue
The Journal of Neuroscience
Published
2010-12-01
Volume
30
Issue
48
Pages
16383-16390
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1979552960
Cited by
277
References
47
Citations by year
2026: 12 · 2025: 5 · 2024: 16 · 2023: 19 · 2022: 11 · 2021: 13 · 2020: 31 · 2019: 23 · 2018: 18 · 2017: 15 · 2016: 19 · 2015: 15 · 2014: 23 · 2013: 23 · 2012: 23
FWCI
5.78
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Wellcome Trust (080513, 86419)
  • Alzheimer's Society
  • University College London
  • European Commission
  • Eisai
  • Directorate for Biological Sciences
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
oligodendrocyte precursor cells, PDGFRA, oligodendrocyte differentiation, astrocyte differentiation, demyelination, experimental autoimmune encephalomyelitis, multiple sclerosis, myelination, reactive astrocytes, spinal cord
MeSH terms
Chondroitin Sulfate Proteoglycan 4, Animals, Antigens, Astrocytes, Demyelinating Diseases, Encephalomyelitis, Autoimmune, Experimental, Female, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Neuroglia, Oligodendroglia, Proteoglycans, Mice, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review